Record Q1 Revenue and Growth
Axon reported first quarter revenue of $604 million, representing a 31% increase year-over-year. This marks the 13th consecutive quarter with over 25% growth.
Strong Bookings and Pipeline
Q1 bookings were strong, with a great indicator of momentum. The company expects another record for annual bookings with growth rates similar to last year.
Software and Services Growth
Software and Services revenue increased by 39% year-over-year to $263 million, driven by digital evidence management and premium add-ons.
TASER 10 Rapid Adoption
TASER 10 orders are pacing at 2x the rate of adoption compared to TASER 7, indicating strong market acceptance and growth potential.
International Expansion
International bookings are off to a strong start, with demand in regions such as Australia, Latin America, Canada, Asia, the UK, and Europe.
Adjusted EBITDA Margin and ARR
Axon delivered a 25.7% adjusted EBITDA margin with $1.1 billion in Annual Recurring Revenue (ARR), a 34% increase year-over-year.
Guidance Increase for 2025
Axon raised its revenue guidance for 2025 to a range of $2.6 billion to $2.7 billion, representing 27% annual growth at the midpoint.